Author： Schlesselman James Reis Isildinha
Publisher： Informa Healthcare
ISSN： 0735-7907
Source： Cancer Investigation, Vol.24, Iss.4, 2006-07, pp. : 404-412
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Phase I and II clinical trials of trastuzumab
By Baselga J.
Annals of Oncology, Vol. 12, Iss. 12, 2001-12 ,pp. :
Access to resources
Recommend
Clinical Trials in Oncology and Defining Benefit
The Oncologist, Vol. 23, Iss. 1, 2018-01 ,pp. :
By Rothenberg M.L. Liu P.Y. Wilczynski S. Hannigan E.V. Weiner S.A. Weiss G.R. Hunter V.J. Chapman J.A. Tiersten A. Kohler P.C. Alberts D.S.
Gynecologic Oncology, Vol. 82, Iss. 2, 2001-08 ,pp. :
By Gridelli C. Perrone F. Gallo C. De Marinis F. Ianniello G. Cigolari S. Cariello S. Di Costanzo F. D'Aprile M. Rossi A. Migliorino R. Bartolucci R. Bianco A.R. Pergola M. Monfardini S.
European Journal of Cancer, Vol. 33, Iss. 3, 1997-03 ,pp. :
Randomised Consent Designs in Cancer Clinical Trials
By Altman D.G. Whitehead J. Parmar M.K.B. Stenning S.P. Fayers P.M. Machin D.
European Journal of Cancer, Vol. 31, Iss. 12, 1995-11 ,pp. :